PRECEDE

Researchers introduced PRECEDE, a precedent-guided AI approach for drug redesign that mitigates side effects while preserving therapeutic benefits, using large language models coordinated with human o…

A new pancreatic cancer drug, Daraxonrasib, has doubled median survival rates for patients with advanced metastatic disease, earning a standing ovation at a major oncology conference. The breakthrough…